Skip to main content

Table 1 Clinical information for binding assay studies

From: Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue

 

Age (Years)

Gender (M/F)

ApoE (E/E)

Braak stage

Postmortem delay (hours)

Alzheimer cases

59

F

4/4

5

4

61

M

3/3

5

4

66

F

4/3

5

7

70

M

4/4

4

4

75

F

4/4

5

6

78

M

4/4

5

7

81

F

4/3

5

6

85

F

3/3

4

6

72 ± 9

3 M/5 F

2 E3

4-5

5 ± 1

6 E4

Controls

50

F

3/3

1

17

62

M

3/3

1

7

71

F

3/2

1

7

77

F

3/3

1

3

78

M

3/3

1

7

79

M

3/3

2

9

81

M

3/3

2

8

84

F

3/3

1

4

73 ± 11

4 M/4 F

8 E3

1-2

8 ± 4

0 E4

  1. The table presents information for the binding studies cases from which homogenates have been extracted. The age at death, gender, apolipoprotein E (ApoE) genotype, Braak stage at cerebral pathological assessment, and post-mortem delay are given for each patient included in the study
  2. M = male; F = Female. Temporal lobes from AD cases mentioned in bold have been used for the saturation and competition studies, as well as the hippocampus from the 75 years-old AD case